Evaluation of proanthocyanidins in treating Type 2 diabetic osteoporosis via SIRT6 /Nrf2/ GPX4 pathways
The FASEB Journal · 2025
DOI: 10.1096/fj.202403032r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Run-Xun Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Osteoporosis, Sirtuins, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Zhejiang Provincial Administration of Traditional Chinese Medicine, Wenzhou Science and Technology Bureau, Zhejiang Traditional Chinese Medicine Administration.
Abstract (Originalsprache)
This study investigates the therapeutic potential of proanthocyanidins (PAC) in addressing Type 2 diabetic osteoporosis (T2DOP) by activating the SIRT6/Nrf2/GPX4 signaling pathways. T2DOP is characterized by compromised bone structure and heightened oxidative stress, where ferroptosis plays a pivotal role. Utilizing a T2DOP mouse model and MC3T3‐E1 cells under high glucose conditions, we evaluated the impact of PAC on bone health and iron homeostasis. Our results, obtained through micro‐CT, histological staining, Western blot, and immunofluorescence analyses, revealed reductions in bone density and decreased GPX4 expression in T2DOP conditions, indicating ferroptosis and oxidative stress. However, PAC treatment improved trabecular bone structure, reduced bone marrow adipocytes, decreased oxidative stress, and enhanced expression of key osteogenic proteins. These findings highlight PAC's potential in mitigating T2DOP through the SIRT6/Nrf2/GPX4 pathways, offering promising therapeutic insights for managing diabetic osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, China
ORCID-Profile: Run-Xun Ma, Bing-Hao Lin, Si-Xiang Feng, Yi-Tian Bu, Zi-Hao Chen, Yi-Xun Huang, En-Li Li, She-Ji Weng, Lei Yang
Förderung
- Zhejiang Provincial Administration of Traditional Chinese Medicine
- Wenzhou Science and Technology Bureau
- Zhejiang Traditional Chinese Medicine Administration
- Wenzhou Municipal Science and Technology Bureau
Zitieren
APA
Ma, R. X., Lin, B. H., Feng, S. X., Bu, Y. T., Chen, Z. H., Huang, Y. X., Li, E. L., Weng, S. J., & Yang, L. (2025). Evaluation of proanthocyanidins in treating Type 2 diabetic osteoporosis via SIRT6 /Nrf2/ GPX4 pathways. The FASEB Journal. https://doi.org/10.1096/fj.202403032r
Vancouver
Ma RX, Lin BH, Feng SX, Bu YT, Chen ZH, Huang YX, et al. Evaluation of proanthocyanidins in treating Type 2 diabetic osteoporosis via SIRT6 /Nrf2/ GPX4 pathways. The FASEB Journal. 2025. doi:10.1096/fj.202403032r
BibTeX
@article{Ma2025,
author = {Ma, Run-Xun and Lin, Bing-Hao and Feng, Si-Xiang and Bu, Yi-Tian and Chen, Zi-Hao and Huang, Yi-Xun and Li, En-Li and Weng, She-Ji and Yang, Lei},
title = {Evaluation of proanthocyanidins in treating Type 2 diabetic osteoporosis via SIRT6 /Nrf2/ GPX4 pathways},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202403032r}
}
EUVIMED